Evidence and Outcomes in Atopic Dermatitis

2016-12-19 20:07:00
Tags: Atopic Dermatitis,Crisaborole,pediatric eczema,psoriasis,severe Atopic Dermatitis,Ustekinumab,specialty pharmacy

Panelists Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Ed Pezalla, MD, MPH; Jonathan Silverberg, MD, PhD, MPH; and Cheryl Allen, BS Pharm, MBA, provide insight on the evidence and outcomes in atopic dermatitis and how they impact coverage.